Advanced search    

Search: authors:"J. D. Long"

5 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Conspecifics, not pollen, reduce omnivore prey consumption

. Rinehart. Methodology: S. Rinehart, J. D. Long. Project administration: S. Rinehart. Resources: S. Rinehart. Software: S. Rinehart. Supervision: J. D. Long. Validation: S. Rinehart. Visualization: S ... . Rinehart. Writing ? original draft: S. Rinehart, J. D. Long. Writing ? review & editing: S. Rinehart, J. D. Long. 14 / 15 1. Pimm SL , Lawton JH ( 1978 ) On feeding on more than one trophic level . Nature

Neonatal hyperglycemia and diminished long-term growth in very low birth weight preterm infants

OBJECTIVE:To investigate the association between early hyperglycemia and growth and development from hospital discharge to 2 years corrected age (CA) in very low birth weight (VLBW) infants.STUDY DESIGN:Blood glucose levels during the first 14 days after birth, weight, length and occipital-frontal circumference (OFC) at birth, hospital discharge and 4, 12 and 24 months CA, Bayley...

A Phaeocystis globosa bloom associated with upwelling in the subtropical South Atlantic Bight

We observed an unusual, subtropical bloom of Phaeocystis globosa Scherffel during a strong upwelling event and confirmed its identity using morphological, physiological and genetic traits. This low-latitude bloom of P. globosa colonies occurred on the South Atlantic Bight continental shelf during the summer of 2003. Maximum chlorophyll a concentration measured during this...

Huntington’s disease cerebrospinal fluid seeds aggregation of mutant huntingtin

Huntington’s disease (HD), a progressive neurodegenerative disease, is caused by an expanded CAG triplet repeat producing a mutant huntingtin protein (mHTT) with a polyglutamine-repeat expansion. Onset of symptoms in mutant huntingtin gene-carrying individuals remains unpredictable. We report that synthetic polyglutamine oligomers and cerebrospinal fluid (CSF) from BACHD...

Management of secretions in esophageal cancer patients with glycopyrrolate

Background: There has been little emphasis in the past upon management of excessive secretions in patients with esophageal cancer. We used the drug glycopyrrolate for controlling secretions in patients with esophageal cancer. Patients and methods: Between January 1991 and September 1995, 45 patients with esophagus cancer were referred for evaluation. Seven of these patients were...